11:14 : Regeneron Pharmaceuticals ([[REGN]] +13.1%) CEO Len Schleifer gives an ... -
Regeneron Pharmaceuticals (REGN +13.1%) CEO Len Schleifer gives an interesting peak under the hood in an earnings CC on how big pharma deals with the sticky issue of how to motivate doctors to load up on drug inventory ...
13:54 : Shares of Regeneron Pharmaceuticals ([[REGN]] +7.8%) are higher today ... -
Shares of Regeneron Pharmaceuticals (REGN +7.8%) are higher today on the news of rival Roche's Avastin problems. Its own macular degeneration treatment Eylea, which competes with Avastin, is currently awaiting FDA approval. ...